Immediate Impact
1 from Science/Nature 66 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Chia-Chun Hsu being referenced
Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chia-Chun Hsu | 152 | 84 | 66 | 92 | 13 | 412 | |
| Alison L. Kearney | 273 | 51 | 35 | 52 | 13 | 457 | |
| Ashok Mandala | 128 | 24 | 36 | 122 | 16 | 347 | |
| Tomomi Hashidate‐Yoshida | 244 | 64 | 52 | 61 | 17 | 423 | |
| Rachel Zhande | 301 | 73 | 44 | 75 | 9 | 457 | |
| Lisa Philp | 124 | 33 | 73 | 84 | 15 | 420 | |
| Patrik Strömberg | 182 | 39 | 34 | 43 | 20 | 447 | |
| Kyung-Hee Hong | 164 | 99 | 89 | 87 | 13 | 442 | |
| I-K Lee | 152 | 74 | 30 | 57 | 8 | 365 | |
| Blandine Secco | 223 | 36 | 109 | 71 | 12 | 431 | |
| Thomas Plötz | 178 | 164 | 64 | 49 | 12 | 422 |
All Works
Login with ORCID to disown or claim papers
Loading papers...